Church of PeptidesSearch
Portrait of TB-500
Pilgrim · Experimental · identity concerns

TB-500

The Wanderer

Thymosin research: United States · TB-500 marketing lineage: uncertain

TB-500 is a name used for products associated with thymosin beta-4 research. The exact peptide matters: a short fragment and the full-length molecule are different substances, and neither a familiar name nor a related mechanism proves injury recovery.

Evidence ladder: In-vitro mechanismEvidence ladder: Unsupported claimEducational record
ClassificationPilgrims
Evidence summaryLaboratory identification · therapeutic benefit unestablished
OriginThymosin research: United States · TB-500 marketing lineage: uncertain
Scientific record

What the evidence says

Roles or demonstrated benefits

  • Thymosin beta-4 biology includes actin binding and cell-migration pathways.
  • Those mechanisms motivate research into repair and regeneration.
  • Evidence about native thymosin beta-4 cannot automatically be assigned to every TB-500 product.

Risks, side effects, and limits

  • Robust therapeutic human evidence for marketed TB-500 is lacking.
  • Exact sequence, purity, sterility, and product identity may be uncertain.
  • WADA prohibits thymosin beta-4 and derivatives including TB-500.
Doctide’s verdict

The Wanderer must first identify what is in the vial. Doctide will not transfer a full-length molecule’s research credentials to a differently defined fragment or accept identity testing as evidence of healing.

Documented history

Where the story actually begins

Anti-doping researchers investigated products marketed as TB-500 and identified an acetylated seven-amino-acid fragment of thymosin beta-4. Their work focused on metabolism and detection. That analytical history helps explain why a marketed label must not be treated as proof of a specific therapeutic substance. Historical source.

Thymosin research: United States · TB-500 marketing lineage: uncertain
Book of the Canon · Comic scripture

The laboratory legend

The Wanderer claimed every road led to repair. Doctide asked him to state his exact amino-acid sequence. The room became suddenly, scientifically quiet.

This bold passage is invented comedy, not scientific or historical fact.
Editorial recordProfile editorial revision: October 4, 2026Prepared under the Church of Peptides evidence standardEditorial review: Church of PeptidesIndependent clinical review: none to dateContent evidence reviewed: September 12, 2026
Evidence ledger

Sources

  1. WADA TB-500 research
  2. WADA prohibited list

Fiction disclosure: The bold laboratory legend above is invented. The historical and scientific sections are intended as sourced summaries; no invented connective events were added to the documented history.

Educational entertainment only. Not medical advice, diagnosis, dosing guidance, or a recommendation to obtain or use a product.